Updates are available Correction dated 2018-11-23
Click to view Correction: https://doi.org/10.1038/s41551-018-0331-x
Updates are available Correction dated 2025-02-05
Click to view Correction: https://doi.org/10.1038/s41551-025-01358-z
-
Authors
Islam, Mohammad Ariful
Xu, Yingjie
Tao, Wei https://orcid.org/0000-0002-4277-3728
Ubellacker, Jessalyn M.
Lim, Michael
Aum, Daniel
Lee, Gha Young
Zhou, Kun
Zope, Harshal
Yu, Mikyung
Cao, Wuji
Oswald, James Trevor
Dinarvand, Meshkat
Mahmoudi, Morteza https://orcid.org/0000-0002-2575-9684
Langer, Robert
Kantoff, Philip W.
Farokhzad, Omid C.
Zetter, Bruce R.
Shi, Jinjun https://orcid.org/0000-0001-9200-5068
- License Information
-
More Information
Article History
Received: 10 November 2016
Accepted: 30 July 2018
First Online: 17 September 2018
Change Date: 23 November 2018
Change Type: Correction
Change Details: The authors wish to add the following sentence into the ‘Competing interests’ section of this Article: “P.W.K. has investment interest in Context Therapeutics LLC, DRGT, Placon, Seer Biosciences and Tarveda Therapeutics, is a company board member for Context Therapeutics LLC, is a consultant and scientific advisory board member for BIND Biosciences, Inc., BN Immunotherapeutics, DRGT, GE Healthcare, Janssen, Metamark, New England Research Institutes, Inc., OncoCellMDX, Progenity, Sanofi, Seer Biosciences, Tarveda Therapeutics and Thermo Fisher, and serves on data safety monitoring boards for Genentech/Roche and Merck.” This has now been included.
Change Date: 5 February 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41551-025-01358-z
Competing interests
: O.C.F. and R.L. declare financial interests in Selecta Biosciences, Tarveda Therapeutics, Placon Therapeutics and Seer. R.L. declares financial interests in Moderna Therapeutics. P.W.K. has investment interest in Context Therapeutics LLC, DRGT, Placon, Seer Biosciences and Tarveda Therapeutics, is a company board member for Context Therapeutics LLC, is a consultant and scientific advisory board member for BIND Biosciences, Inc., BN Immunotherapeutics, DRGT, GE Healthcare, Janssen, Metamark, New England Research Institutes, Inc., OncoCellMDX, Progenity, Sanofi, Seer Biosciences, Tarveda Therapeutics and Thermo Fisher, and serves on data safety monitoring boards for Genentech/Roche and Merck.
